FSCN1 and ovarian serous adenocarcinoma: In another study, Daponte et al. [127] showed FSCN1 expression in advanced poorly differentiated serous ovarian cancer that was associated with poor prognosis, suggesting FSCN1 as an independent prognostic biomarker.